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        The CD8  T cell response to an acute systemic 
infection entails vigorous expansion of antigen-
specifi  c cells, followed by a contraction phase in 
which 90  –  95% of the cells die by apoptosis. The 
cells remaining after the contraction phase be-
come memory T cells, which possess properties 
distinct from the naive population, such as rapid 
acquisition of eff  ector function on reencounter 
with pathogen. Accumulating evidence suggests 
that naive CD8  T cells are programmed to be-
come memory cells in the early phase of the 
CD8  T cell response, when appropriate signals 
from the TCR, co-stimulatory molecules, and 
cytokines associated with infl   ammation are 
thought to be required (  1, 2  ). 
  IL-2, which is produced by activated T cells, 
is one of the cytokines involved in the CD8  T 
cell response. IL-2 induces intracellular signals 
through the IL-2 receptor complex, consisting 
of CD25 (IL-2R     ), CD122 (IL-2/IL-15R     ), 
and CD132 (common       chain). Stimulation of 
the receptor complex by IL-2 induces several 
signal transduction pathways, including the acti-
vation of STAT5 (  3  ). Recent studies have dem-
onstrated that IL-2 supports the maintenance of 
Foxp3  CD4  regulatory T cells, which bear 
the IL-2R      chain (CD25) (  4  –  6  ). The require-
ment for IL-2 signals to maintain regulatory T 
cells limits the use of cytokine or cytokine re-
ceptor knockout mice to study other in vivo roles 
of IL-2. Instead, the eff  ect of IL-2 signals on 
CD8  T cells during an immune response has 
been investigated by creating situations in which 
CD25, CD122, or IL-2 are selectively defi  cient 
in CD8  T cells. These studies revealed a mod-
est role for IL-2 in the primary expansion and 
diff   erentiation of CTL (  7  –  12  ), whereas IL-2 
appears to support expansion of primary CTL 
in nonlymphoid organs (  13  ). Very recently, 
another role for IL-2 signals in antigen-stimu-
lated CD8  T cells was revealed using mixed 
BM chimeric mice containing both wild-type 
CORRESPONDENCE  
  Michael J. Bevan:  
 mbevan@u.washington.edu
  Abbreviations used: C57BL/6, 
B6; HP, homeostatic pro-
liferation; LM-OVA,   Listeria 
monocytogenes    –  expressing soluble 
OVA. 
      The online version of this article contains supplemental material.   
  Naive CD8 T cells diff  erentiate into 
protective memory-like cells after 
IL-2  –  anti  –  IL-2 complex treatment in vivo 
  Daisuke Kamimura and Michael J. Bevan 
  Department of Immunology and Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195   
  An optimal CD8 T cell response requires signals from the T cell receptor (TCR), co-stimu-
latory molecules, and cytokines. In most cases, the relative contribution of these signals to 
CD8 T cell proliferation, accumulation, effector function, and differentiation to memory is 
unknown. Recent work (Boyman, O., M. Kovar, M.P. Rubinstein, C.D. Surh, and J. Sprent. 
2006.   Science  . 311:1924  –  1927; Kamimura, D., Y. Sawa, M. Sato, E. Agung, T. Hirano, and 
M. Murakami. 2006.   J. Immunol.   177:306  –  314) has shown that anti  –  interleukin (IL) 2 
monoclonal antibodies that are neutralizing in vitro enhance the potency of IL-2 in vivo. 
We investigated the role of IL-2 signals in driving CD8 T cell proliferation in the absence 
of TCR stimulation by foreign antigen. IL-2 signals induced rapid activation of signal 
transducer and activator of transcription 5 in all CD8 T cells, both naive and memory 
phenotype, and promoted the differentiation of naive CD8 T cells into effector cells. 
IL-2  –  anti  –  IL-2 complexes induced proliferation of naive CD8 T cells in an environment 
with limited access to self  –  major histocompatibility complex (MHC) and when competition 
for self-MHC ligands was severe. After transfer into wild-type animals, IL-2  –  activated CD8 
T cells attained and maintained a central memory phenotype and protected against lethal 
bacterial infection. IL-2  –  anti  –  IL-2 complex  –  driven memory-like CD8 T cells had incom-
plete cellular fi  tness compared with antigen-driven memory cells regarding homeostatic 
turnover and cytokine production. These results suggest that intense IL-2 signals, with 
limited contribution from the TCR, program the differentiation of protective memory-like 
CD8 cells but are insuffi  cient to guarantee overall cellular fi  tness. 1804 PROGRAMMING MEMORY CD8  T CELLS BY IL-2 SIGNALS | Kamimura and Bevan
In addition, after treatment with IL-2  –  anti  –  IL-2 com-
plexes,   almost the entire CD8  population adopts a CD44  hi   
CD122  hi   phenotype (unpublished data) (  14  ). We therefore 
asked whether CD44  lo   naive CD8  T cells could respond to 
IL-2  –  anti  –  IL-2 complexes injected in vivo. IL-2 signal trans-
duction is known to involve the activation of STAT5, which 
is important for the biological activity of IL-2 (  3, 4  ). There-
fore, we used the phosphorylation status of STAT5 as a read-
out of induction of an IL-2 signal in vivo. C57BL/6 (B6) 
mice were given a single injection of IL-2  –  anti  –  IL-2 com-
plexes, and at the indicated time points, splenocytes were 
fi  xed without restimulation in vitro, and activated (tyrosine-
phosphorylated) STAT5 was detected by fl  ow cytometry. As 
shown in   Fig. 1  , CD44  hi   memory-phenotype CD8  T cells 
responded rapidly after the treatment: the phosphorylation of 
STAT5 was induced in 50% of the population at 15 min 
and increased to  90% by 60 min.   Surprisingly, the rapid ac-
tivation of STAT5 was also observed in CD44  lo   naive CD8  
T cells with slightly delayed kinetics. At 60 min,  80% of the 
CD44  lo   naive CD8  population contained the activated form 
of STAT5. NK cells (NK1.1  TCR       NEG  ) also showed STAT5 
activation, whereas B cells (B220  TCR       NEG  ) showed no de-
tectable activation of STAT5 at 60 min (unpublished data). 
The rapid activation of STAT5 suggests that CD44  lo   naive 
CD8  T cells, as well as memory-phenotype CD8  T cells, 
receive signals directly from IL-2  –  anti  –  IL-2 complexes. 
  IL-2  –  anti  –  IL-2 complexes induce proliferation of naive 
CD8 T cells 
  These results prompted us to examine the physiological con-
sequence of treating naive CD8  T cells with IL-2 signals 
in vivo. Congenically marked CD44  lo   CD122  lo   naive OT-I 
cells were isolated, labeled with CFSE, and transferred into 
nonirradiated syngeneic B6 mice (Fig. S1 A, available at 
http://www.jem.org/cgi/content/full/jem.20070543/DC1). 
After treatment of the host animals with IL-2  –  anti  –  IL-2 com-
plexes, the naive OT-I cells divided extensively (  Fig. 2 A  ) 
and accumulated (  Fig. 2 B  ) in the absence of any other 
stimulation.   The expansion of naive OT-I cells was almost 
equivalent to that of the host CD8  T cell population (  Fig. 2 B  ). 
Surface markers associated with activation/memory, including 
and CD25 /  cells. In these mice a complete compartment of 
regulatory T cells is reconstituted, and the mice remain healthy 
(  11, 12  ). Upon acute infection, eff  ector and memory CD8  T 
cells lacking CD25 were generated and normally maintained, 
but their secondary expansion after pathogen rechallenge was 
severely compromised compared with that of CD25-suffi   cient 
memory cells (  11, 12  ). Intriguingly, replenishment of IL-2 
signals to CD25 /  CD8  T cells during the primary infec-
tion, but not during the secondary challenge, restored their 
ability to expand in a recall response (  11  ). This result clearly 
indicates a programming eff  ect of IL-2 signaling during the 
primary response in driving the complete diff  erentiation of 
memory CD8  T cells. 
  Recent data suggest that the anti  –  IL-2 mAb S4B6, which 
has been widely used as a neutralizing antibody in vitro, en-
hances the bioactivity of IL-2 in vivo (  14, 15  ). Administra-
tion of rIL-2 mixed with the anti  –  IL-2 mAb (IL-2  –  anti  –  IL-2 
complexes) or the concurrent treatment with plasmid DNA 
expressing mouse IL-2 and the antibody substantially and 
preferentially increased the proliferation of CD44  hi   CD122  hi   
memory-phenotype CD8  T cells and NK cells (  14, 15  ). In-
jection of anti  –  IL-2 mAb alone had a similar eff  ect because 
of the capture of endogenously secreted IL-2 by the mAb, 
although the effi   cacy of this treatment is much weaker than 
the cotreatment with IL-2  –  anti  –  IL-2 complexes (  14, 15  ). The 
precise mechanism of the enhanced potency of the immune 
complex remains unclear, although the presentation of 
IL-2  –  anti  –  IL-2 complexes via the Fc portion of the mAb has 
been suggested (  14  ). 
  We report that the administration of IL-2  –  anti  –  IL-2 
complexes stimulated all CD8  T cells, both naive and mem-
ory phenotype, in vivo. The naive CD8  T cells proliferated, 
became eff  ector cells, and diff  erentiated to memory-pheno-
type cells capable of providing protection against pathogen 
challenge. Remarkably, proliferation of naive CD8  T cells 
by treatment with IL-2  –  anti  –  IL-2 complexes was induced in 
the absence of foreign antigen and when competition for self-
MHC class I ligands was intense. Because most experimental 
systems used for the study of CD8  T cell responses are asso-
ciated with strong TCR stimulation, our approach using 
IL-2  –  anti  –  IL-2 complexes allowed us to dissect and examine the 
relative contribution of IL-2 and antigen signals to CD8  T cell 
responses, revealing that intense IL-2 signals coupled with 
weak TCR ligation have the potential to program the diff  eren-
tiation of protective memory-like CD8  T cells in vivo. 
    RESULTS   
  IL-2  –  anti  –  IL-2 complexes activate STAT5 in all CD8 T cells 
  CD44  hi   CD122  hi   memory-phenotype CD8+ T cells and NK 
cells express high levels of CD122 (IL-2/IL-15R     ), providing 
an explanation for the preferential expansion of these popula-
tions after treatment with complexes of rIL-2 and anti  –  IL-2 
mAb (IL-2  –  anti  –  IL-2 complexes) (  14, 15  ). However, CD44  lo   
naive CD8  T cells also express detectable levels of CD122, 
intermediate between those of memory-phenotype CD8  
T cells and naive CD4  T cells (unpublished data) (  16  ). 
  Figure 1.     IL-2  –  anti  –  IL-2 complex treatment induces rapid activa-
tion of STAT5 in naive CD8 T cells. Mice were given a single injection 
of IL-2  –  anti  –  IL-2 complexes. At the indicated time points, splenocytes 
were fi  xed and permeabilized for intracellular staining of the tyrosine-
phosphorylated form of STAT5. Mice for the zero time point received no 
injection. The data are gated on the CD8  population, and the numbers 
represent the percentage of gated cells in each quadrant.     JEM VOL. 204, August 6, 2007 
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CD27, CD44, and CD122, were up-regulated on OT-I cells 
that received IL-2 signals, whereas CD62L and CD127 levels 
remained unchanged as compared with OT-I cells in animals 
receiving control injections (  Fig. 2 C  ). This phenotype re-
sembles a central memory phenotype (  17  ). IL-2  –  anti  –  IL-2 
complex  –  mediated proliferation in a lympho-replete envi-
ronment was not unique to OT-I cells or mediated by a sec-
ond TCR possibly expressed on TCR-transgenic cells, because 
other naive TCR-transgenic CD8  T cells (from P14 or V     5 
TCR-transgenic mice) and OT-I cells on a RAG-1    −  /  −    back-
ground also proliferated (Fig. S2). In contrast, proliferation of 
naive polyclonal CD8  T cells was not as vigorous (unpub-
lished data), as previously reported (  14  ). Functionally, OT-I 
cells that had received IL-2 signals were able to produce IFN-      
after a 4-h stimulation with their cognate peptide in vitro (  Fig. 
2 D  ) and killed target cells in an antigen-specifi  c manner in 
vivo (  Fig. 2 E  ), both of which are typical characteristics of 
eff  ector cells. These results indicate that signals provided by 
IL-2  –  anti  –  IL-2 complexes induce the proliferation and activa-
tion of naive antigen-specifi  c CD8  T cells in nonlymphopenic 
environments without cognate antigen stimulation. 
  Fc     receptors are dispensable for the action of IL-2  –  anti  –
  IL-2 complexes 
  Why IL-2  –  anti  –  IL-2 complexes are so potent in vivo is still 
unclear. One possible mechanism that has been proposed 
is the presentation of IL-2  –  anti  –  IL-2 complexes by Fc  
receptor  –  bearing cells to cells expressing CD122/CD132 (  14  ). 
Thus, IL-2 complexed to F(ab     )  2   fragments of the anti  –  IL-2 
mAb had only a modest eff  ect in vivo (  14  ). To investigate the 
role of Fc  receptors, mice defi  cient in both FcR  chain and 
Fc RII (FcR  / Fc RII / ) were used. Because the FcR  
chain is necessary for surface expression of the activating IgG 
Fc receptors, including Fc RI, III, and IV, whereas the 
  inhibitory receptor Fc RII does not share the FcR  chain 
(  18, 19  ), FcR  / Fc RII /  mice should be devoid of 
known functional Fc  receptors on hematopoietic cells. In 
fact, Fc RII and Fc RIII expression was undetectable on B 
cells from FcR  / Fc RII /  mice by staining with anti-
CD16/32 (Fc RIII/II) mAb (Fig. S3 A, available at http://
www.jem.org/cgi/content/full/jem.20070543/DC1). In ad-
dition, anti-CD3  –  induced cytokine release in vivo, which 
requires presentation and cross-linking via Fc  receptors 
(20, 21), was severely impaired in FcR  / Fc RII /  mice, 
indicating a gross functional defect of Fc  receptors in these 
mice (Fig. S3 B). Because FcR  / Fc RII /  mice are on a 
mixed genetic background, we tested the effi   cacy of IL-2  –
  anti  –  IL-2 complexes by sampling PBLs before and after treat-
ment rather than using an adoptive transfer system. Both 
control and FcR  / Fc RII /  mice displayed a similar small 
population of CD44  hi   CD122  hi   memory-phenotype CD8+ T 
cells before treatment (  Fig. 3 A  ).   By day 5 after treatment with 
  Figure 2.     IL-2  –  anti  –  IL-2 complexes induce proliferation of naive 
antigen-specifi  c CD8 T cells. 0.5   10  6   purifi  ed CD44  lo   CD122 lo   naive 
OT-I cells were transferred into nonirradiated mice on day   −  1. The mice 
were given IL-2  –  anti  –  IL-2 complexes or control (rat IgG) on days 0 and 2, 
and the assays were performed on day 6. (A) Proliferation of donor cells 
was evaluated by CFSE dilution. (B) Absolute number of donor cells (left) 
and host CD8  T cells (right) in the spleen. The data represent the mean   
SEM (  n     3). ***, P   0.001 versus rat IgG treatment. (C) Phenotypic 
changes of the donor cells. Rat IgG and IL-2  –  anti  –  IL-2 complex treatment 
are indicated with open and shaded histograms, respectively. (D) IFN-     
production by donor OT-I cells was assessed after 4 h of stimulation in 
vitro. Numbers represent the percentage of gated OT-I cells making IFN-    . 
(E) Equal numbers (1.1   10  6   cells) of naive OT-I cells and IL-2  –  anti  –  IL-2 
complex  –  activated OT-I cells were transferred to naive animals. An in vivo 
CTL assay with OVA peptide  –  pulsed (CFSE  hi  ) and control (CFSE  lo )  targets 
was performed the next day. The killing activity was examined 20 h later. 
Numbers represent the percentage of CFSE  hi   and CFSE  lo   targets  remaining. 
The donor cells (A  –  D) and target cells (E) were distinguished from host 
populations by congenic markers.     
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reconstituted with syngeneic BM. As shown in   Fig. 4 A  , 
naive OT-I cells underwent three to four divisions in le-
thally irradiated WT hosts after rat IgG treatment, because of 
lymphopenia-induced HP.   Proliferation was delayed in MHC 
class Ia  –  defi  cient hosts, confi  rming that HP of naive CD8  
T cells is MHC class I  –  dependent (  22  –  24  ). In contrast, IL-2 sig-
nals provided by injected IL-2  –  anti  –  IL-2 complexes stimulated 
extensive division of naive OT-I cells in the MHC class Ia  –
  defi  cient and   –  suffi   cient host animals. The recovery of donor 
OT-I cells in the spleen after the complex treatment was also 
similar in both groups (  Fig. 4 B  ). 
  These results suggest a minimal requirement for TCR li-
gation by self-MHC for the proliferation of naive CD8  T cells 
stimulated by IL-2  –  anti  –  IL-2 complexes, but it does not rule 
out the possibility of stimulation by MHC class I molecules 
on the donor cells themselves or by irradiation-induced cyto-
kines. In this regard, a recent report has strongly suggested the 
requirement for TCR recognition of self-MHC ligands to 
observe the accumulation of IL-2  –  driven CD8  cells (  26  ). 
We took a second approach to examine the dependency on 
TCR stimulation based on the fi  nding that adoptively trans-
ferred TCR-transgenic CD8  T cells do not undergo HP in 
hosts with the identical TCR clonotype because of clonal 
competition for MHC class I/peptide ligands (  27, 28  ). Ac-
cordingly, naive OT-I cells were labeled with CFSE and 
transferred into nonirradiated OT-I/RAG-1 /  hosts. As shown 
in   Fig. 4 C  , signals provided by IL-2  –  anti  –  IL-2 complexes 
induced several divisions of naive OT-I cells even in this envi-
ronment, where competition for self-MHC ligands is intense. 
IL-2  –  anti  –  IL-2 complexes, CD44  hi   CD122  hi   memory-
phenotype CD8+ T cells increased dramatically in control and 
FcR  / Fc RII /  mice (  Fig. 3 A  ). Total numbers of PBLs 
increased signifi  cantly after treatment in both strains and cor-
related with vigorous expansion of CD8+ T cells and NK cells 
(  Fig. 3 B  ). These results suggest that Fc  receptor  –  mediated 
presentation is dispensable for the action of IL-2  –  anti  –  IL-2 
complexes in vivo. 
  IL-2  –  anti  –  IL-2 complexes stimulate naive CD8 T cells 
with limited TCR stimulation by self-ligands 
  IL-2 signals induced the proliferation of naive TCR-trans-
genic CD8+ T cells in a complete lymphoid compartment and 
in the absence of cognate antigen stimulation (  Fig. 2 A   and 
Fig. S2). However, it was possible that TCR stimulation by 
self-ligands had an important role, as is the case for homeo-
static proliferation (HP) of naive CD8+ T cells in a lympho-
penic environment (  22  –  24  ). To explore the dependency on 
MHC class I ligands, we chose MHC class I K  b /   D  b /    mice 
as host animals, because the homeostasis of IgG is impaired in 
   2   microglobulin  –  defi  cient mice (  25  ), which might aff  ect the 
half-life of IL-2  –  anti  –  IL-2 complexes. Because CD8  T cells 
transferred into MHC class Ia  –  defi  cient mice were almost 
completely rejected after IL-2  –  anti  –  IL-2 complex treatment 
(unpublished data), MHC class Ia  –  defi  cient mice were irradi-
ated with 10 Gy and transplanted with syngeneic BM cells to 
prevent rejection. Irradiated, BM-reconstituted mice were 
injected with CFSE-labeled naive OT-I cells and IL-2  –  anti  –
  IL-2 complexes. As controls, B6 mice were also irradiated and 
  Figure 3.     Fc  receptors are dispensable for the action of IL-2  –  anti  –  IL-2 complexes. B6 mice and FcR  / Fc RII /  mice were treated with IL-2  – 
anti  –  IL-2 complexes on days 0 and 2. The mice were bled before starting the treatment (pretreatment) and on day 5. (A) Phenotype of the CD8  T cell 
population of the same animal in each group is shown. The data are gated on CD3  CD8  cells. Numbers represent the percentage of gated cells within 
the box. (B) Absolute numbers of total leukocytes, CD8  T cells (CD3  CD8 ), and NK cells (NK1.1  CD3  NEG  ) in the peripheral blood before and after (day 5) 
the treatment. Each column represents the mean   SEM (  n     3). *, P   0.05; or **, P   0.01 versus pretreatment.     JEM VOL. 204, August 6, 2007 
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OT-I cells into B6 recipients, followed by immunization with 
  Listeria monocytogenes    –  expressing soluble OVA (LM-OVA; 
Fig. S1 C). More than 75 d after transfer of the IL-2  –  anti  –  IL-2 
complex  –  driven or antigen-driven memory cells, the OT-I 
cells accounted for     3% of the CD8  population in the spleen 
(  Fig. 5  ).   At this point, the antigen-driven memory OT-I cells 
were CD44  hi   CD122  hi   and contained CD62L  hi   central and 
CD62L  lo   eff  ector memory subsets. In contrast, all of the IL-2  –
  anti  –  IL-2 complex  –  driven cells had the phenotype of central 
memory cells. These results suggest that naive CD8  T cells 
activated by IL-2  –  anti  –  IL-2 complex treatment revert to stable 
central memory-phenotype cells. 
  IL-2  –  anti  –  IL-2 complex memory CD8 T cells protect 
against bacterial infection 
  Functional memory CD8  T cells rapidly expand in num-
bers and eff  ectively control a challenge with pathogen (  1, 2  ). 
We therefore assessed the ability of IL-2  –  anti  –  IL-2 complex 
memory OT-I cells to mount a protective recall response to 
a lethal dose of LM-OVA. Mice bearing IL-2  –  anti  –  IL-2 
complex memory OT-I/RAG-1 /  cells (91 d after transfer) 
were infected with a lethal dose of LM-OVA. As shown in 
  Fig. 6 (A and B)  , IL-2  –  anti  –  IL-2 complex memory OT-I/
RAG-1 /  cells expanded over 30-fold within 3 d after the 
LM-OVA challenge.   To examine the protective ability of 
IL-2  –  driven memory cells, a control group of mice received 
1.5   10  6   untreated OT-I/RAG-1 /  cells to constitute a 
population of these cells at an equivalent level to that of mice 
containing IL-2  –  anti  –  IL-2 complex memory OT-I/RAG-
1 /  cells (132 d after transfer). Before challenge with LM-
OVA, the OT-I donor cell populations in peripheral blood 
were 1.3   0.11% and 1   0.04% of CD8  T cells in control 
and IL-2  –  anti  –  IL-2 complex memory groups, respectively. 
At 3 d after challenge, mice containing IL-2  –  anti  –  IL-2 com-
plex memory OT-I/RAG-1 /  cells were able to signifi  cantly 
decrease LM-OVA burden in both the spleen and liver com-
pared with mice containing untreated OT-I/RAG-1 /  cells 
and mice without cell transfer (  Fig. 6 C  ). Furthermore, adop-
tive transfer of IL-2  –  anti  –  IL-2 complex memory OT-I cells 
provided signifi  cant protection to naive animals, whereas an 
equal number of naive OT-I cells did not (Fig. S4, available at 
http://www.jem.org/cgi/content/full/jem.20070543/DC1). 
These results demonstrate that IL-2 –  anti  –  IL-2 complex –  driven 
memory CD8  T cells are able to mount a rapid and robust 
response to antigen challenge and aff  ord protection. 
  IL-2  –  anti  –  IL-2 complex memory CD8 T cells display 
incomplete cellular fi  tness 
  We further characterized IL-2  –  anti  –  IL-2 complex memory 
OT-I cells, and compared them to LM-OVA memory OT-I 
cells and with spontaneously arising memory-phenotype 
CD8  T cells. Memory CD8  T cells proliferate slowly to 
maintain a stable pool (  6, 24  ), and this homeostatic turnover 
can be measured by the uptake of BrdU. LM-OVA anti-
gen-driven memory OT-I cells displayed a rate of homeo-
static turnover that was similar to that of memory-phenotype 
This result suggested that robust expansion of naive CD8  T 
cells in response to potent IL-2 signals requires only minimal 
TCR stimulation. 
  IL-2  –  anti  –  IL-2 complexes generate memory cells 
with a central memory phenotype 
  We next addressed whether naive CD8  T cells activated by 
IL-2  –  anti  –  IL-2 complexes could diff  erentiate to memory cells. 
OT-I mice were injected with IL-2  –  anti  –  IL-2 complexes, re-
sulting in the conversion of almost all the CD8  T cells to a 
CD44  hi   CD122  hi   activated phenotype (Fig. S1 B). 15   10  6   
IL-2  –  activated OT-I cells were then transferred at day 12 to 
normal B6 hosts. At 1 d after transfer, the OT-I cells exhibited 
rapid IFN-  production in response to peptide stimulation 
in vitro (unpublished data). For comparison, conventional, 
antigen-driven OT-I cells were generated by transfer of 10  4   naive 
  Figure 4.     IL-2  –  anti  –  IL-2 complexes stimulate naive CD8 T cells 
with limited TCR stimulation. Host mice that received CFSE-labeled naive 
OT-I cells 1 d earlier were treated with IL-2  –  anti  –  IL-2 complexes on days 0 
and 2. CFSE levels of donor cells from the spleen were examined on day 6. 
The data are gated on CD3  CD8  congenically marked donor cells. (A) WT 
and MHC class I K  b /  D b /  mice that were irradiated with 10 Gy and 
transplanted with syngeneic BM cells were used as host animals. (B) Abso-
lute number of OT-I cells recovered from the spleen of animals in A is shown. 
The data represent the mean + SEM (  n     2). ***, P   0.001 versus rat IgG 
treatment. (C) Nonirradiated OT-I/RAG-1 /  mice were used as hosts.    1808 PROGRAMMING MEMORY CD8  T CELLS BY IL-2 SIGNALS | Kamimura and Bevan
    DISCUSSION   
  The recent realization that complexing IL-2 with anti  –  IL-2 
mAbs leads to a dramatic increase in the potency of signaling 
via the intermediate affi   nity CD122/CD132 receptor in vivo 
(  14, 15  ) allowed us to examine the consequences of such sig-
nals to CD8  T cells in normal, nonlymphopenic animals in 
the absence of foreign antigen stimulation. Injected IL-2  –
  anti  –  IL-2 complexes caused the rapid activation of STAT5 in 
naive as well as memory-phenotype CD8  T cells (  Fig. 1  ). 
This was the case even though CD122 levels are much higher 
on memory than on naive CD8  T cells (unpublished data) (  16  ) 
and the IL-2 –  anti  –  IL-2 complex signaling depends on CD122 
(  29  ). Under such conditions, potent IL-2 signals stimulated 
naive CD8  T cells to proliferate and diff  erentiate into func-
tional memory cells. Such IL-2  –  anti  –  IL-2 complex  –  driven 
memory cells had a conventional central memory phenotype 
(  Fig. 5  ) and were able to control a bacterial challenge in both 
lymphoid and nonlymphoid organs (  Fig. 6 C   and Fig. S4). The 
downstream molecular basis for the IL-2  –  anti  –  IL-2 complex  –
  driven programming of memory CD8  T cells awaits further 
investigation. Target genes of STAT5, an important compo-
nent of IL-2 signaling (  3, 4  ), are likely to be a key component 
of this process, because overexpression of STAT5 in T cells 
results in the selective expansion of memory-phenotype CD8  
T cells (  30, 31  ). 
  Although IL-2  –  anti  –  IL-2 complex  –  generated memory 
CD8  T cells were able to expand, accumulate, and provide 
protection after challenge with a high dose   Listeria   infection 
(  Fig. 6   and Fig. S4), we found that they diff  ered from conven-
tional antigen-driven memory cells. In comparison with con-
ventional memory cells, they had a slower rate of homeostatic 
turnover and reduced cytokine production after short-term 
restimulation (  Fig. 7  ). This slow turnover may result in dis-
appearance of the complex-driven memory cells in the long 
term, although a clear correlation between the reduced BrdU 
uptake and loss of donor cells was not consistently observed 
up to 80 d after transfer (unpublished data). The turnover of 
CD8  T cells in the same mouse (  Fig. 7 A  ).   In contrast, al-
though IL-2  –  anti  –  IL-2 complex memory OT-I cells also 
exhibited homeostatic turnover, the rate was signifi  cantly less 
than that of antigen-driven memory cells or CD44  hi   CD122  hi   
memory-phenotype CD8  T cells in the same mouse (  Fig. 7, 
A and B  ). 
  Another cardinal feature of memory CD8  T cells is the 
rapid production of cytokines after reencounter with antigen 
(  1, 2  ). Splenocytes containing IL-2  –  anti  –  IL-2 complex mem-
ory OT-I cells or LM-OVA memory OT-I cells were stimu-
lated with OVA peptide or PMA plus ionomycin for 4 h in 
vitro, and cytokine production was assessed by fl  ow cytometry. 
Upon antigenic stimulation, almost all ( 95%) antigen-driven 
memory cells produced IFN- ; most of the IFN-       –  producing 
population also produced TNF- , and     40% of them were 
IL-2 positive (  Fig. 7 C  ). In comparison, a reduced fraction of 
memory cells generated by IL-2  –  anti  –  IL-2 complexes were 
positive for the cytokines tested (  Fig. 7 C  ). In addition, the 
amounts of IFN- , TNF- , and IL-2 produced on a per-cell 
basis, as judged by the mean fl  uorescence intensity, were 
also decreased in IL-2  –  anti  –  IL-2 complex memory OT-I 
cells compared with antigen-driven memory cells (  Fig. 7 D  ). 
Diff  erences in cytokine production were evident when IL-2 
complex  –  driven or antigen-driven memory cells were stimu-
lated with PMA plus ionomycin (  Figs. 7, E and F  ), implying 
that alterations in signal transduction proximal to the TCR do 
not account for the changes. The cytokine production levels of 
IL-2  –  anti  –  IL-2 complex memory OT-I cells resembled those 
of the host memory-phenotype CD8  T cells upon PMA/
ionomycin stimulation, although a marked diff  erence was ob-
served in IFN-  levels (  Fig. 7 F  ). Similar results were obtained 
when activated OT-I cells were prepared from OT-I/RAG-
1 /  mice that had been treated with IL-2  –  anti  –  IL-2 com-
plexes (  Fig. 7 B   and not depicted). These results suggest that 
strong IL-2 signals coupled with weak TCR signals are not 
suffi   cient to guarantee the overall cellular fi  tness of memory 
CD8  T cells. 
  Figure 5.     IL-2  –  anti  –  IL-2 complexes generate memory cells with a central memory phenotype. Memory OT-I cells generated by LM-OVA infection 
(75 d after infection; population A), IL-2  –  anti  –  IL-2 complex memory OT-I cells (12 d of treatment plus 76 d after transfer; population B), and host 
CD8  T cells (population C) were examined for the expression of cell-surface markers. Contour plots are gated on CD8  cells. Numbers represent the 
percentage of CD8  cells within the box.     JEM VOL. 204, August 6, 2007 
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interesting to note that naive CD8  T cells that receive strong 
TCR signals after pathogen infection, but weak or no IL-2 
signals (i.e., IL-2R         −  /  −    cells), develop into memory cells that 
show normal levels of homeostatic turnover and cytokine pro-
duction but fail to accumulate in response to secondary anti-
genic challenge (  11  ). Thus, predominant TCR signals without 
IL-2 give rise to memory CD8  T cells that fail to accumulate 
in response to a secondary challenge, whereas predominant 
IL-2 signals with weak TCR stimulation result in memory 
cells with reduced turnover and cytokine production. 
  IL-2  –  anti  –  IL-2 complexes dramatically enhance IL-2 
activity in vivo (  14, 15  ), but the mechanism of this enhance-
ment is still unclear. Because IL-2  –  anti  –  IL-2 complexes lack-
ing the Fc region (i.e., IL-2 plus the F(ab     )  2   portion of the 
anti  –  IL-2 mAb) had less activity than complexes with the 
whole IgG, it was suggested that Fc  receptor  –  positive cells 
in lymphoid organs presented the IL-2 to T cells (  14  ). How-
ever, we show that IL-2  –  anti  –  IL-2 complexes showed similar 
potent activity in FcR  / Fc RII /  mice as in B6 control 
mice (  Fig. 3  ). It is possible that other nonclassical Fc receptor  –
  like molecules (  32  ) or leaky expression of Fc RI without the 
FcR  subunit (  33  ) may mediate the activity of IL-2  –  anti  – 
IL-2 complexes in vivo. However, FcR  / Fc RII−/− mice 
showed a gross functional defect in the stimulatory presenta-
tion of anti-CD3 IgG (Fig. S3 B), leading us to conclude that 
presentation of IL-2  –  anti  –  IL-2 complexes via Fc      receptors 
may not be responsible for the enhancing eff  ect. The half-life 
of IgG in vivo is dependent on the presence of the Fc region 
(  25, 34  ), and this may explain the weak activity of IL-2  –  anti  –
  IL-2 immune complexes lacking Fc. Moreover, there are 
many studies documenting the fact that the in vivo half-life of 
various cytokines is prolonged by the formation of immune 
complexes. These include human IL-2  –  anti  –  IL-2 (  35  ), IL-4  –
  anti  –  IL-4 (  36  ), IL-6  –  anti  –  IL-6 (  37  ), and soluble IL-15  –  IL-
15R -Fc (  38  ) complexes. Therefore, we favor the idea that 
IL-2  –  anti  –  IL-2 complexes extend the half-life of IL-2 in vivo 
by preventing renal excretion, the major pathway of IL-2 clear-
ance in mice (  39  ). 
  Other recent reports have demonstrated the development 
of memory CD8  T cells from naive cells without cognate 
antigen stimulation. Stimulation of naive CD8  T cells with sol-
uble IL-15  –  IL-15R      complexes, which act as superagonists (  40, 
41  ), induced proliferation and converted the cells to memory-
phenotype CD8  T cells (  38  ). Because both soluble IL-15  –  IL-
15R      complexes and IL-2  –  anti  –  IL-2 immune complexes signal 
through the CD122/CD132 receptor complex on CD8  T 
cells (  6, 42  ), these two types of complex may result in similar 
consequences, although the function of the memory-pheno-
type CD8  T cells generated by soluble IL-15  –  IL-15R      com-
plexes was not addressed in detail (  38  ). In another report, 
Hamilton et al. demonstrated that lymphopenia-induced HP 
resulted in the generation of protective memory-like CD8  T 
cells (  43  ). Similar to IL-2  –  anti  –  IL-2 complex  –  mediated prolif-
eration, HP is induced in the absence of cognate antigen (  22  –
  24  ), and similar phenotypic changes occur after proliferation 
induced by IL-2 signals (  Fig. 2 C and Fig. 5  ) and by HP (  43  ). 
memory CD8  T cells is regulated by cytokines such as IL-7 
and IL-15 (  6  ). The expression levels of the receptors for 
these cytokines, namely CD127 (IL-7R ) and CD122 (IL-2/
IL-15R ) and CD132, did not noticeably diff  er between 
complex-driven memory cells, antigen-driven memory cells, 
and memory-phenotype cells (  Fig. 5   and not depicted). In 
addition, treatment with PMA plus ionomycin did not over-
ride the defect in cytokine production of IL-2  –  anti  –  IL-2 com-
plex memory CD8  T cells (  Fig. 7, E and F  ), implying that the 
reduced fi  tness of IL-2  –  anti  –  IL-2 complex memory CD8  
T cells might be caused by intracellular diff  erences, such as in 
the epigenetic remodeling of genes involved in hallmark char-
acteristics of memory cells. We speculate that more potent 
signals via the TCR may be required to operate in conjunc-
tion with IL-2 signals to promote the complete programming 
of memory CD8  T cell diff  erentiation. In this context, it is 
  Figure 6.     IL-2  –  anti  –  IL-2 complex memory CD8 T cells protect 
against bacterial infection. (A)  Enumeration  of  IL-2 – anti – IL-2  complex 
memory OT-I/RAG-1 /  cells (9 d of treatment and 91 d after transfer; 
CD45.2 ) in the spleen before and 3 d after challenge with 10  5   CFU  of 
LM-OVA. The data are gated on CD8  cells. Numbers represent the per-
centage of CD8  cells within the box. (B) Absolute numbers of IL-2  –  anti  –
  IL-2 complex memory OT-I/RAG-1 /  cells in the spleen before and after 
LM-OVA challenge. Data represent the mean + SEM (  n     3  –  4). ***, P   
0.001. (c) CFU of LM-OVA in the spleen and liver at 3 d after challenge of 
mice containing equal numbers of naive OT-I/RAG-1 /   or  IL-2 – anti – IL-2 
memory OT-I/RAG-1 /  cells. Data represent the mean + SEM (  n      4 – 6). 
***, P   0.001 versus the OT-I/RAG-1 /  group.     1810 PROGRAMMING MEMORY CD8  T CELLS BY IL-2 SIGNALS | Kamimura and Bevan
programming memory CD8  T cell diff  erentiation may reside 
within pathways common to these stimulations. 
  MATERIALS AND METHODS 
  Mice.     B6 mice were obtained from the Jackson Laboratory. B6.SJL, MHC 
class I Kb / D  b /   , OT-I/RAG-1 / , and FcR  / Fc RII /  mice were 
purchased from Taconic. These animals were backcrossed to a B6 genetic 
background, except for FcR  / Fc RII /  mice, which were on a 129   B6 
mixed background. Animals were housed in specifi  c pathogen-free condi-
tions in the animal facilities at the University of Washington. OT-I TCR-
transgenic mice (  47  ) congenic for Thy1.1 and CD45.1 were bred and 
maintained in the same facilities. All experiments were performed in compliance 
HP of naive CD8  T cells in a lymphopenic environment 
requires both TCR stimulation through MHC class I  –  peptide 
complexes, in addition to cytokines such as IL-7 (  22  –  24  ). Pro-
liferation of naive CD8  cells driven by IL-2  –  anti  –  IL-2 com-
plexes in irradiated mice may also require TCR signals from 
self-MHC ligands (  26  ). IL-7  –  dependent HP is enhanced by 
IL-12, but no substantial involvement of IL-2 has been re-
ported (  44  –  46  ). Given that stimulation by foreign antigen plus 
cytokines (such as pathogen infections), self-antigen plus IL-7 
(HP), or intense IL-2 signals (IL-2  –  anti  –  IL-2 complexes) all give 
rise to protective memory CD8  T cells, key components of 
  Figure 7.     IL-2  –  anti  –  IL-2 complex memory CD8 T cells display incomplete cellular fi  tness. (A) Mice bearing LM-OVA antigen-driven memory 
OT-I cells at 68 d after infection or IL-2  –  anti  –  IL-2 complex memory OT-I cells after 81 d (12 d of treatment plus 69 d after transfer) were given BrdU in 
drinking water for 7 d. BrdU incorporation by the indicated subsets of memory CD8  T cells in the spleen is shown. Numbers represent the percentage of 
gated cells that are BrdU positive. (B) BrdU-positive population of host CD44  hi   CD122 hi   CD8 +   T cells and IL-2  –  anti  –  IL-2 complex memory OT-I/RAG-1 /  
cells after 61 d (9 d of treatment plus 52 d after transfer). The data are the mean   SEM (  n     3). *, P       0.05. (C  –  F) Splenocytes containing memory OT-I 
cells generated by LM-OVA infection (62 d after infection) or IL-2 signals (12 d of treatment plus 63 d after transfer) were stimulated in vitro with OVA 
peptide (C and D) or PMA plus ionomycin (E and F). Intracellular cytokine production was examined 4 h later. Numbers in C and E represent the percent-
age of gated cells in each quadrant. (D and F) The mean fl  uorescent intensity (MFI) of cytokine staining is shown (mean   SEM;   n     3). The MFI was 
calculated within the population positive for the respective cytokine. * and **, P   0.05 and 0.001, respectively, versus the complex-driven memory cells; 
***, P   0.001 versus LM-OVA memory cells.     JEM VOL. 204, August 6, 2007 
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provided by H. Shen (University of Pennsylvania School of Medicine, Phila-
delphia, PA) (  51  ). LM-OVA was grown in Brain-Heart Infusion broth (BD 
Biosciences). At a midlog growth phase, culture samples were measured by 
OD and diluted in PBS for the desired titers. For preparation of LM-OVA  –
  induced OT-I memory cells, mice that received 10  4   CD44  lo   CD122  lo   naive 
OT-I cells per mouse 1 or 2 d earlier were infected i.v. with 3,000 CFU of 
LM-OVA. These mice were used at least 50 d later. Engraftment of the donor 
cells at the time of assay was between 1 and 10% of total CD8  T cells. For 
lethal infection, mice were inoculated i.v. with 10  5   CFU. For protection 
assay, organ suspension was prepared in 5 ml PBS, and 10-fold serial dilutions 
were made in PBS containing 0.1% NP-40. These 100-     l dilutions were 
plated onto the Brain-Heart Infusion plates containing 5      g/ml erythromycin. 
The limit of detection was 50 CFU per organ. 
  Statistical analysis.     Data with logarithmic presentation were transformed 
to log  10   (  43  ). Statistical diff  erences between groups were examined by a paired, 
two-tailed (for   Fig. 3 B  ) or an unpaired, two-tailed Student  ’  s   t   test using Prism 
software (GraphPad). P   0.05 was considered statistically signifi  cant. 
  Online supplemental material.     Fig. S1 shows the experimental protocols 
used for studying IL-2  –  anti  –  IL-2 complex  –  induced proliferation and for the 
generation of IL-2  –  anti  –  IL-2 complex memory and antigen-driven memory 
cells. Fig. S2 shows the proliferation of diff  erent kinds of TCR-transgenic 
CD8  T cells induced by IL-2  –  anti  –  IL-2 complexes. Fig. S3 shows the sur-
face staining and the functional defect in FcR  / Fc RII /  mice. Fig. S4 
shows the protection against bacterial challenge aff  orded by an equal number 
of naive OT-I, IL-2  –  anti  –  IL-2 complex memory OT-I, or LM-OVA  –  induced 
memory OT-I. Online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20070543/DC1. 
  We thank Beverly Dere and Xiao-cun Pan for excellent technical support. 
  This work was supported by the Howard Hughes Medical Institute and 
National Institutes of Health grant AI19335 (to M.J. Bevan). 
  The authors have no confl  icting fi  nancial interests. 
Submitted:   16 March 2007 
Accepted:   5 July 2007 
  REFERENCES 
       1  .   Haring  ,   J.S.  ,   V.P.     Badovinac  , and   J.T.     Harty  .   2006  .   Infl  aming  the 
CD8  T cell response.       Immunity    .   25  :  19    –    29  .   
       2  .   Williams  ,   M.A.  , and   M.J.     Bevan  .   2007  .   Eff  ector and memory CTL 
diff  erentiation.       Annu. Rev. Immunol.       25  :  171    –    192  .   
       3  .   Lin  ,   J.X.  , and   W.J.     Leonard  .   2000  .   The role of Stat5a and Stat5b in 
signaling by IL-2 family cytokines.       Oncogene    .   19  :  2566    –    2576  .   
       4  .   Malek  ,   T.R.  , and   A.L.     Bayer  .   2004  .   Tolerance, not immunity, crucially 
depends on IL-2.       Nat. Rev. Immunol.       4  :  665    –    674  .   
       5  .   Sakaguchi  ,   S.  ,   M.     Ono  ,   R.     Setoguchi  ,   H.     Yagi  ,   S.     Hori  ,   Z.     Fehervari  ,   J.   
  Shimizu  ,   T.     Takahashi  , and   T.     Nomura  .   2006  .   Foxp3+ CD25+ CD4+ 
natural regulatory T cells in dominant self-tolerance and autoimmune 
disease.       Immunol. Rev.       212  :  8    –    27  .   
       6  .   Ma  ,  A.  ,  R.    Koka  , and  P.    Burkett  .  2006  .  Diverse functions of IL-2, IL-15, 
and IL-7 in lymphoid homeostasis.       Annu. Rev. Immunol.       24  :  657    –    679  .   
       7  .   D  ’  Souza  ,  W.N.  , and  L.    Lefrancois  .  2003  .  IL-2 is not required for the initiation 
of CD8 T cell cycling but sustains expansion.       J. Immunol.       171  :  5727    –    5735  .   
       8  .   Yu  ,   A.  ,   J.     Zhou  ,   N.     Marten  ,   C.C.     Bergmann  ,   M.     Mammolenti  ,   R.B.   
  Levy  , and   T.R.     Malek  .   2003  .   Effi   cient induction of primary and sec-
ondary T cell-dependent immune responses in vivo in the absence of 
functional IL-2 and IL-15 receptors.       J. Immunol.       170  :  236    –    242  .   
       9  .   D  ’  Souza  ,   W.N.  , and   L.     Lefrancois  .   2004  .   Frontline: An in-depth evalu-
ation of the production of IL-2 by antigen-specifi  c CD8 T cells in vivo.   
    Eur. J. Immunol.       34  :  2977    –    2985  .   
        10  .   Teague  ,   R.M.  ,   R.M.     Tempero  ,   S.     Thomas  ,   K.     Murali-Krishna  , and 
  B.H.     Nelson  .   2004  .   Proliferation and diff  erentiation of CD8+ T cells 
in the absence of IL-2/15 receptor beta-chain expression or STAT5 
activation.       J. Immunol.       173  :  3131    –    3139  .   
with the University of Washington Institutional Animal Care and Use Com-
mittee regulations. 
  Preparation of IL-2  –  anti  –  IL-2 complexes.     Carrier-free recombinant 
mouse IL-2 was obtained from eBioscience. Hybridoma of anti  –  IL-2 mAb 
(S4B6) was grown in HB basal medium with HB101 supplement (Irvine-
Scientifi  c). The anti  –  IL-2 mAb was purifi  ed from the culture medium with 
a protein G column. IL-2  –  anti  –  IL-2 complexes were prepared by mixing 
1.5  g rIL-2 and 50  g anti  –  IL-2 mAb per mouse. Rat IgG (Sigma-Aldrich) 
plus PBS was used as a control treatment, as previously described (  15, 48  ). 
The dose of IL-2  –  anti  –  IL-2 complexes has been shown to be eff  ective in vivo 
in previous studies (  11, 14  ). 
  Detection of phospho-STAT5 in vivo.     Mice were killed at the time 
points indicated in the fi  gures after a single i.p. injection of IL-2  –  anti  –  IL-2 
complexes. The intracellular phospho-STAT5 staining was performed as 
previously described (  49, 50  ). In brief, splenocytes were fi  xed in 1.6% formal-
dehyde/PBS for 30 min at room temperature, followed by permeabilization 
with ice-cold methanol. The fi  xed and permeabilized cells were stained in 
2% FCS/PBS with PECy7-labeled anti-CD44, PerCP-labeled anti-CD8 , 
and Alexa Fluor 647  –  labeled anti  –  phospho-STAT5 (Y694; Phosfl  ow, BD 
Biosciences) mAbs. Alexa Fluor 647  –  labeled mouse IgG1 mAb (Phosfl  ow; 
BD Biosciences) was used as the isotype control. 
  Adoptive transfer of donor CD8 T cells.     CD44  lo   naive CD8  T cells 
were purifi  ed by magnetic cell sorting using the CD8a  T cell isolation kit 
(Miltenyi Biotec) supplemented with 0.003      g per million cells of biotinylated 
anti-CD44 mAb (BD Biosciences) to deplete CD44  hi   CD8  T cells (  46  ). After 
sorting,   >  98% of CD8  T cells were CD44  lo   CD122  lo   naive phenotype. 0.5  –  10  6   
donor cells per mouse were transferred i.v. into nonirradiated hosts. In some 
experiments, the donor cells were labeled with 1.6      M CFSE (Invitrogen) 
for 10 min at 37  °  C before transfer. Host animals in Fig. 4 (A and B) received 
10 Gy total body irradiation and were reconstituted with syngeneic BM 
trans  plantation. For assays of IL-2  –  anti  –  IL-2 complex memory cells, OT-I or 
OT-I/RAG-1 /  mice were injected with IL-2  –  anti  –  IL-2 complexes fi  ve to 
six times every other day until most OT-I CD8  T cells acquired the CD44  hi   
CD122  hi   phenotype. These cells were isolated by the magnetic cell sorting sys-
tem without biotinylated anti-CD44 mAb. 7  –  17   10  6   of these activated OT-I 
cells per mouse were injected i.v. into host mice. The analysis of memory OT-I 
cells was performed at least 50 d after transfer. Engraftment of the donor cells 
at the time of assay was between 1 and 10% of total CD8  T cells. 
  Intracellular cytokine staining.     Splenocytes were incubated with 1  g/
ml OVA  257-264   (SIINFEKL) or PMA plus ionomycin in the presence of 
Brefeldin A (GolgiPlug; BD Biosciences) for 4 h at 37 C. After staining of 
cell-surface molecules, the cells were fi  xed and permeabilized with the 
Cytofi  x/Cytoperm kit (BD Biosciences). The intracellular cytokine staining 
was performed with FITC-labeled anti  –  TNF-     , PE-labeled anti  –  IL-2, and 
PECy7-labeled IFN-      mAbs (eBioscience). 
  In vivo CTL assay.     To prepare target cells, splenocytes were incubated 
with or without 10  g/ml OVA  257-264   peptide for 30 min at 37 C. These 
peptide-pulsed target and nontarget populations were labeled with 1.6 and 
0.16  M CFSE, respectively, mixed at a 1:1 ratio, and injected i.v. into 
mice. After 20 h, the target cell killing activity was evaluated using the ratio 
of CFSE/positive populations in the spleen. The CFSE-labeled populations 
were distinguished from host populations by congenic markers. 
  BrdU labeling in vivo.     Mice were given 0.8 mg/ml BrdU (Sigma-Aldrich) 
in their drinking water for 7 d. Intracellular BrdU staining was performed by 
following the instructions of the BrdU Flow Kit (BD Biosciences). 
  LM-OVA infection, generation of LM-OVA  –  induced memory OT-I 
cells, and protection assay.     An erythromycin-resistant recombinant strain 
of   L. monocytogenes   that expresses a secreted form of OVA (LM-OVA) was 1812 PROGRAMMING MEMORY CD8  T CELLS BY IL-2 SIGNALS | Kamimura and Bevan
homeostasis: development of CD4+CD25+ regulatory T cells versus 
CD8+ memory T cells.       J. Immunol.       171  :  5853    –    5864  .   
        32  .   Davis  ,   R.S.     2007  .   Fc receptor-like molecules.       Annu. Rev. Immunol.     
  25  :  525    –    560  .   
        33  .   Barnes  ,   N.  ,   A.L.     Gavin  ,   P.S.     Tan  ,   P.     Mottram  ,   F.     Koentgen  , and   P.M.   
  Hogarth  .   2002  .   FcgammaRI-defi  cient mice show multiple alterations to 
infl  ammatory and immune responses.       Immunity    .   16  :  379    –    389  .   
        34  .   Ghetie  ,   V.  , and   E.S.     Ward  .   2000  .   Multiple roles for the major histo-
compatibility complex class I-related receptor FcRn.       Annu. Rev. Immunol.     
  18  :  739    –    766  .   
        35  .   Courtney  ,   L.P.  ,   J.L.     Phelps  , and   L.M.     Karavodin  .   1994  .   An anti-IL-2 
antibody increases serum half-life and improves anti-tumor effi   cacy of 
human recombinant interleukin-2.       Immunopharmacology    .   28  :  223    –    232  .   
        36  .   Finkelman  ,   F.D.  ,   K.B.     Madden  ,   S.C.     Morris  ,   J.M.     Holmes  ,   N.     Boiani  , 
  I.M.     Katona  , and   C.R.     Maliszewski  .   1993  .   Anti-cytokine antibodies as 
carrier proteins. Prolongation of in vivo eff  ects of exogenous cytokines 
by injection of cytokine-anti-cytokine antibody complexes.       J. Immunol.     
  151  :  1235    –    1244  .   
        37  .   May  ,   L.T.  ,   R.     Neta  ,   L.L.     Moldawer  ,   J.S.     Kenney  ,   K.     Patel  , and   P.B.   
  Sehgal  .  1993  .  Antibodies chaperone circulating IL-6. Paradoxical eff  ects of 
anti-IL-6   “  neutralizing  ”   antibodies in vivo.       J. Immunol.       151  :  3225    –    3236  .   
        38  .   Stoklasek  ,   T.A.  ,   K.S.     Schluns  , and   L.     Lefrancois  .   2006  .   Combined 
IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo.   
    J. Immunol.       177  :  6072    –    6080  .   
        39  .   Donohue  ,   J.H.  , and   S.A.     Rosenberg  .   1983  .   The fate of interleukin-2 
after in vivo administration.       J. Immunol.       130  :  2203    –    2208  .   
        40  .   Rubinstein  ,   M.P.  ,   M.     Kovar  ,   J.F.     Purton  ,   J.H.     Cho  ,   O.     Boyman  ,   C.D.   
  Surh  , and   J.     Sprent  .   2006  .   Converting IL-15 to a superagonist by binding 
to soluble IL-15R  {  alpha  }  .       Proc. Natl. Acad. Sci. USA    .   103  :  9166    –    9171  .   
        41  .   Mortier  ,   E.  ,   A.     Quemener  ,   P.     Vusio  ,   I.     Lorenzen  ,   Y.     Boublik  ,   J.   
  Grotzinger  ,   A.     Plet  , and   Y.     Jacques  .   2006  .   Soluble interleukin-15 re-
ceptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of 
IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15   ×   IL-
15R alpha fusion proteins.       J. Biol. Chem.       281  :  1612    –    1619  .   
        42  .   Waldmann  ,   T.A.     2006  .   The biology of interleukin-2 and interleu-
kin-15: implications for cancer therapy and vaccine design.       Nat. Rev. 
Immunol.       6  :  595    –    601  .   
        43  .   Hamilton  ,   S.E.  ,   M.C.     Wolkers  ,   S.P.     Schoenberger  , and   S.C.     Jameson  . 
  2006  .   The generation of protective memory-like CD8+ T cells during 
homeostatic proliferation requires CD4+ T cells.       Nat. Immunol.       7  :  475    –    481  .   
        44  .   Rocha  ,   B.  ,   M.P.     Lembezat  ,   A.     Freitas  , and   A.     Bandeira  .   1989  . 
  Interleukin 2 receptor expression and interleukin 2 production in expo-
nentially growing T cells: major diff  erences between in vivo and in vitro 
proliferating T lymphocytes.       Eur. J. Immunol.       19  :  1137    –    1145  .   
        45  .   Cho  ,   B.K.  ,   V.P.     Rao  ,   Q.     Ge  ,   H.N.     Eisen  , and   J.     Chen  .   2000  . 
  Homeostasis-stimulated proliferation drives naive T cells to diff  erentiate 
directly into memory T cells.       J. Exp. Med.       192  :  549    –    556  .   
        46  .   Kieper  ,  W.C.  ,  M.    Prlic  ,  C.S.    Schmidt  ,  M.F.    Mescher  , and  S.C.    Jameson  . 
  2001  .   IL-12 enhances CD8 T cell homeostatic expansion.       J. Immunol.     
  166  :  5515    –    5521  .   
        47  .   Hogquist  ,   K.A.  ,   S.C.     Jameson  ,   W.R.     Heath  ,   J.L.     Howard  ,   M.J.     Bevan  , 
and   F.R.     Carbone  .   1994  .   T cell receptor antagonist peptides induce 
positive selection.       Cell    .   76  :  17    –    27  .   
        48  .   Ku  ,   C.C.  ,   M.     Murakami  ,   A.     Sakamoto  ,   J.     Kappler  , and   P.     Marrack  . 
  2000  .   Control of homeostasis of CD8+ memory T cells by opposing 
cytokines.       Science    .   288  :  675    –    678  .   
        49  .   Krutzik  ,   P.O.  ,   M.R.     Clutter  , and   G.P.     Nolan  .   2005  .   Coordinate analy-
sis of murine immune cell surface markers and intracellular phosphopro-
teins by fl  ow cytometry.       J. Immunol.       175  :  2357    –    2365  .   
        50  .   Long  ,   M.  , and   A.J.     Adler  .   2006  .   Cutting edge: Paracrine, but not au-
tocrine, IL-2 signaling is sustained during early antiviral CD4 T cell 
response.       J. Immunol.       177  :  4257    –    4261  .   
        51  .   Pope  ,   C.  ,   S.K.     Kim  ,   A.     Marzo  ,   D.     Masopust  ,   K.     Williams  ,   J.     Jiang  ,   H.   
  Shen  , and  L.    Lefrancois  .  2001  .  Organ-specifi  c regulation of the CD8 T cell 
response to   Listeria monocytogenes   infection.       J. Immunol.       166  :  3402    –    3409  .                     
        11  .   Williams  ,   M.A.  ,   A.J.     Tyznik  , and   M.J.     Bevan  .   2006  .   Interleukin-2 
signals during priming are required for secondary expansion of CD8+ 
memory T cells.       Nature    .   441  :  890    –    893  .   
        12  .   Bachmann  ,   M.F.  ,   P.     Wolint  ,   S.     Walton  ,   K.     Schwarz  , and   A.     Oxenius  . 
  2007  .   Diff  erential role of IL-2R signaling for CD8+ T cell responses in 
acute and chronic viral infections.       Eur. J. Immunol.       37  :  1502    –    1512  .   
        13  .   D  ’  Souza  ,   W.N.  ,   K.S.     Schluns  ,   D.     Masopust  , and   L.     Lefrancois  .   2002  . 
  Essential role for IL-2 in the regulation of antiviral extralymphoid CD8 
T cell responses.       J. Immunol.       168  :  5566    –    5572  .   
        14  .   Boyman  ,   O.  ,   M.     Kovar  ,   M.P.     Rubinstein  ,   C.D.     Surh  , and   J.     Sprent  . 
  2006  .   Selective stimulation of T cell subsets with antibody-cytokine 
immune complexes.       Science    .   311  :  1924    –    1927  .   
        15  .   Kamimura  ,   D.  ,   Y.     Sawa  ,   M.     Sato  ,   E.     Agung  ,   T.     Hirano  , and   M.   
  Murakami  .   2006  .   IL-2 in vivo activities and antitumor effi   cacy  en-
hanced by an anti-IL-2 mAb.       J. Immunol.       177  :  306    –    314  .   
        16  .   Zhang  ,   X.  ,   S.     Sun  ,   I.     Hwang  ,   D.F.     Tough  , and   J.     Sprent  .   1998  .   Potent 
and selective stimulation of memory-phenotype CD8+ T cells in vivo 
by IL-15.       Immunity    .   8  :  591    –    599  .   
        17  .   Wherry  ,   E.J.  ,   V.     Teichgraber  ,   T.C.     Becker  ,   D.     Masopust  ,   S.M.   
  Kaech  ,   R.     Antia  ,   U.H.     von Andrian  , and   R.     Ahmed  .   2003  .   Lineage 
relationship and protective immunity of memory CD8 T cell subsets.   
    Nat. Immunol.       4  :  225    –    234  .   
        18  .   Ravetch  ,   J.V.  , and   S.     Bolland  .   2001  .   IgG Fc receptors.       Annu. Rev. 
Immunol.       19  :  275    –    290  .   
        19  .   Nimmerjahn  ,   F.  ,   P.     Bruhns  ,   K.     Horiuchi  , and   J.V.     Ravetch  .   2005  . 
  FcgammaRIV: a novel FcR with distinct IgG subclass specifi  city.   
    Immunity    .   23  :  41    –    51  .   
      20  .   Alegre  ,   M.L.  ,   J.Y.     Tso  ,   H.A.     Sattar  ,   J.     Smith  ,   F.     Desalle  ,   M.     Cole  , and 
  J.A.     Bluestone  .   1995  .   An anti-murine CD3 monoclonal antibody with 
a low affi     nity for Fc gamma receptors suppresses transplantation re-
sponses while minimizing acute toxicity and immunogenicity.       J. Immunol.     
  155  :  1544    –    1555  .   
        21  .   Vossen  ,   A.C.  ,   G.J.     Tibbe  ,   M.J.     Kroos  ,   J.G.     van de Winkel  ,   R.     Benner  , 
and   H.F.     Savelkoul  .   1995  .   Fc receptor binding of anti-CD3 monoclonal 
antibodies is not essential for immunosuppression, but triggers cytokine-
related side eff  ects.       Eur. J. Immunol.       25  :  1492    –    1496  .   
        22  .   Goldrath  ,   A.W.  , and   M.J.     Bevan  .   1999  .   Low-affi   nity ligands for the 
TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts.   
    Immunity    .   11  :  183    –    190  .   
        23  .   Prlic  ,   M.  , and   S.C.     Jameson  .   2002  .   Homeostatic expansion versus an-
tigen-driven proliferation: common ends by diff  erent means?       Microbes 
Infect.       4  :  531    –    537  .   
        24  .   Surh  ,   C.D.  , and   J.     Sprent  .   2005  .   Regulation of mature T cell homeostasis.   
    Semin. Immunol.       17  :  183    –    191  .   
        25  .   Junghans  ,   R.P.  , and   C.L.     Anderson  .   1996  .   The protection receptor for 
IgG catabolism is the beta2-microglobulin-containing neonatal intesti-
nal transport receptor.       Proc. Natl. Acad. Sci. USA    .   93  :  5512    –    5516  .   
        26  .   Cho  ,   J.H.  ,   O.     Boyman  ,   H.-O.     Kim  ,   B.     Hahm  ,   M.P.     Rubinstein  ,   C.D.   
  Surh  , and   J.     Sprent  .   2007  .   An intense form of homeostatic proliferation 
of naive CD8  +   cells driven by IL-2.       J. Exp. Med.       204  :  1787    –    1801  .   
        27  .   Troy  ,   A.E.  , and   H.     Shen  .   2003  .   Cutting edge: homeostatic prolifera-
tion of peripheral T lymphocytes is regulated by clonal competition.     
  J. Immunol.       170  :  672    –    676  .   
        28  .   Kieper  ,   W.C.  ,   J.T.     Burghardt  , and   C.D.     Surh  .   2004  .   A role for TCR 
affi   nity in regulating naive T cell homeostasis.       J. Immunol.       172  :  40    –    44  .   
        29  .   Kamimura  ,  D.  ,  N.    Ueda  ,  Y.    Sawa  ,  S.    Hachida  ,  T.    Atsumi  ,  T.    Nakagawa  , 
  S.     Sawa  ,   G.H.     Jin  ,   H.     Suzuki  ,   K.     Ishihara  ,   et al  .   2004  .   Evidence of a 
novel IL-2/15R beta-targeted cytokine involved in homeostatic prolif-
eration of memory CD8+ T cells.       J. Immunol.       173  :  6041    –    6049  .   
        30  .   Kelly  ,   J.  ,   R.     Spolski  ,   K.     Imada  ,   J.     Bollenbacher  ,   S.     Lee  , and   W.J.   
  Leonard  .   2003  .   A role for Stat5 in CD8+ T cell homeostasis.       J. Immunol.     
  170  :  210    –    217  .   
        31  .   Burchill  ,   M.A.  ,   C.A.     Goetz  ,   M.     Prlic  ,   J.J.     O  ’  Neil  ,   I.R.     Harmon  ,   S.J.   
  Bensinger  ,   L.A.     Turka  ,   P.     Brennan  ,   S.C.     Jameson  , and   M.A.     Farrar  . 
  2003  .   Distinct eff  ects of STAT5 activation on CD4+ and CD8+ T cell 